Posted: May 25, 2011 8:32 AM by Tracy Wirtz
Updated: May 25, 2011 8:42 AM
Click here to reserve your St. Jude Dream Home ticket!
The students of Cathedral Carmel in downtown Lafayette gathered Monday to walk in support of one of their school mates. 12-year-old Alyssa Babineaux is a St. Jude patient who was diagnosed with neuroblastoma in June of 2007. Neuroblastoma is a cancer that attacks the nervous system and can be difficult to treat. They managed to get her cancer under control the first time and then she relapsed. They got it under control again with an experimental antibody treatment, but it has returned. Her dad Roy says they found three small spots: one on her arm, one on her back and one in her hip. She is currently undergoing oral chemo treatments to shrink the tumors. Hopefully, this treatment works and then she will undergo another antibody treatment. Alyssa says the first antibody treatment was painful but she is not afraid. In fact, she calls St. Jude Children's Research Hospital fun and amazing, and says they really care about her. And we know they do!
The antibody treatment is experimental but Roy says the doctors at St. Jude have explained everything to them. Basically, these lab-created antibodies are given to Alyssa through an IV. The antibodies bind to the neuroblastoma or cancer cells and destroy them. It's groundbreaking research and treatment, and part of what St. Jude is known the world over for... finding effective treatments to save the lives of children.
Roy knows that they would not have Alyssa today if it weren't for St. Jude. All of her treatment and everything associated with it is covered because that is part of the St. Jude mission. They want to make children better; they want to find cures for catastrophic illness. And they want the families to focus on the children and their well-being, not the next bill that may come in the mail.
You can help in the fight against childhood cancer and catastrophic diseases by reserving your St. Jude Dream Home ticket today. Click here for more information.